What is the maximum take-home supply for Orlaam?

The maximum take-home supply for Orlaam (which is a brand name for levo-alpha-acetylmethadol or LAAM) is set at 2 weeks. This regulation is established under federal opioid treatment program guidelines, which aim to ensure that patients receiving medication-assisted treatment for opioid dependence have ongoing access to their medications while also minimizing the risk of misuse or diversion.

Allowing a take-home supply for 2 weeks strikes a balance between providing patients with adequate access to their medication to maintain stability in their treatment and implementing necessary controls to monitor use and prevent abuse. This provision is crucial in the context of ensuring that patient care is both effective and safe. In contrast, longer take-home supplies (like 30 days) are generally not permitted for this medication due to the potential risks associated with extended access without regular monitoring.